Fluconazole treatment of fungal UTIs in pediatric patients

Durwood E. Neal, Gabriel Rodriguez, J. Alison Hanson, Edwin Harmon

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Fungal urinary tract infections (UTIs) are relatively uncommon but increasing in incidence. Despite the variety of agents available to treat these infections, they remain a therapeutic challenge to clinicians. Amphotericin B has traditionally been the drug of choice for systemic fungal infections, but its use is limited by frequent and severe adverse effects such as fever, chills, nausea, and phlebitis. Three pediatric patients with Candida infections were treated successfully with fluconazole (3 to 5mg/ kg per day). Although it is not currently indicated for children, fluconazole appears to be a safe and effective treatment for UTIs caused by Candida organisms in these patients.

Original languageEnglish (US)
Pages (from-to)169-170+177
JournalInfections in Medicine
Volume13
Issue number3
StatePublished - Dec 1 1996
Externally publishedYes

Keywords

  • Amphotericin B
  • Candida
  • Fluconazole
  • Infections, fungal
  • Infections, urinary tract

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Fluconazole treatment of fungal UTIs in pediatric patients'. Together they form a unique fingerprint.

  • Cite this

    Neal, D. E., Rodriguez, G., Hanson, J. A., & Harmon, E. (1996). Fluconazole treatment of fungal UTIs in pediatric patients. Infections in Medicine, 13(3), 169-170+177.